ICRC-Weyer GmbH

TFF Pharmaceuticals | July 30, 2020

TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today commented on the initial results of research evaluating the development of remdesivir as a dry powder for inhalation by Thin Film Freezing. Findings of the study conducted by a team of researchers at the University of Texas at Austin’s Division of Molecular Pharmaceutics and Drug Delivery...

Business Insights

FGC Health | March 04, 2022

FGC Health, a national leader in consumer health services, industry-specific business tools and provider of an industry-leading proprietary open-source platform, announced today it has acquired Pharmacy Access Solutions Inc. (PASI), an industry leader in the development of real-time, smart technology solutions in support of automated patient-centric programs and professional service modules, as well as financial and performance reporting for independent owners and banner groups. PASI will contin...

openPR | April 08, 2020

Advance Market Analytics released the research report of Global Medical Morphine Market, offers a detailed overview of the factors influencing the global business scope. Medical Morphine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Medical Morphine. This Report covers the emerging player's data, including: competitive situatio...

FiercePharma | March 26, 2020

After nearly five years and significant investment, commercial production is again underway at a plant that was once the poster-child of pharma production quality failures. Following a January inspection, the FDA has given its nod of approval for Xellia Pharmaceuticals to start manufacturing at the sterile injectables plant in the Cleveland, Ohio suburb of Bedford. The Copenhagen, Denmark-based Xellia says it will use the greater capacity to scale up its approved pipeline of antiinfectives and t...